Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023-2024
2023-2024年,在阿拉斯加和美国西南部,Nirsevimab对美国印第安人和阿拉斯加原住民儿童在第一和第二个呼吸道合胞病毒(RSV)流行季期间的RSV相关住院治疗有效。
期刊:Pediatric Infectious Disease Journal
影响因子:2.2
doi:10.1097/INF.0000000000004942
Hammitt, Laura L; Espinoza, Joel S; Keck, James W; Hartman, Rachel M; Alvarez-Colon, Gilberto; Burrage, Amanda; Campbell, Angela P; Cardona, Fernando; Chappell, James; Christensen, Loretta; Dawood, Fatimah S; Desnoyers, Christine; Dobson, Jennifer; Halasa, Natasha; Hurley, Chloe; Larsen, Rebecca; McAuley, James B; McMorrow, Meredith L; Menachof, Kelly; Prill, Mila; Oxley, Linda; Riley, Dennie Parker; Ritchie, Nina; Sandoval, Marqia; Singleton, Rosalyn J; Sutcliffe, Catherine G